Latest Bristol-Myers Squibb Stories
CLARK, N.J., July 10, 2014 /PRNewswire/ -- GEP, a leading provider of procurement and supply chain solutions to Fortune 500 and Global 2000 enterprises worldwide, is pleased to announce that
On July 1, the FDA published that 6 lots of Coumadin (Warfarin Sodium) for Injection, 5 mg single-use vials, by Bristol-Myers Squibb, are recalled due to the presence of visible particulate matter.
LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies.
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival.
SAN DIEGO, June 25, 2014 /PRNewswire/ -- Concortis Biosystems, Inc.
LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Researchers have identified the first genetic variations linked to race that begin to explain a higher risk of death among some African American and Caucasian patients taking the anti-clotting drug clopidogrel (Plavix) after a heart attack.
LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
JACKSONVILLE, Florida, June 17, 2014 /PRNewswire/ -- NGA Human Resources, a leader in Global HR and Payroll, today announced it has been selected by global biopharmaceutical
- A poem in which the author retracts something said in an earlier poem.